Evaluation of the Keratoconic Cornea After Corneal Collagen Cross Linking.
The Role of Anterior Segment Optical Coherence Tomography in Evaluation of the Keratoconic Cornea After Corneal Collagen Cross Linking.
1 other identifier
interventional
44
1 country
1
Brief Summary
Aim of work:
- To detect abnormal corneal thinning in keratoconus using pachymetry maps measured by high-speed anterior segment optical coherence tomography (OCT).
- To evaluate the visualization and depth of the demarcation line with anterior segment optical coherence tomography (AS-OCT) after corneal collagen cross-linking (CXL).
- To compare the depth of demarcation line between epithelial-on (Epi-on) and epithelial-off (Epi-off) corneal collagen cross-linking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 13, 2019
CompletedFirst Posted
Study publicly available on registry
March 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2019
CompletedMarch 19, 2019
March 1, 2019
2.5 years
March 13, 2019
March 17, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
Demarcation line (DL) depth
DL is a hyper-reflectivity seen in the anterior corneal stroma between the crossed and non-crossed collagen stromal bundles using anterior segment optical coherence tomography.
3 months post corneal collagen cross linking
Change in maximum keratometry (K-max) in diopters (D)
to compare preoperative values of K-max with values at both 6 and 12 months follow up visits.
preoperative, 6 months and 12 months postoperative
Change in central corneal thickness in (µm)
using anterior segment OCT
preoperative, 6 months and 12 months postoperative
Secondary Outcomes (3)
Change in visual acuity
preoperative, 6 months and 12 months postoperative
Change in the mean refractive spherical equivalent (MRSE)
preoperative, 6 months and 12 months postoperative
Change in pachymetry at the thinnest location
preoperative, 6 months and 12 months postoperative
Study Arms (2)
Group 1 (Epithelium-off accelerated CXL)
ACTIVE COMPARATORpatients with corneal thickness \> 400 µm (thinnest location) were assigned into Epi-off accelerated CXL procedure
Group 2 (Epithelium-on accelerated CXL)
ACTIVE COMPARATORpatients with corneal thickness \> 380 µm and \< 400 µm thinnest location) were assigned into Epi-on Trans-epithelial accelerated CXL procedure
Interventions
This strategy is based on the underlying pathology of the disease. Corneal collagen cross linking (CXL) idea was based on the fact that a photosensitizer substance like riboflavin (vitamin B2) can interact with ultraviolet irradiation (Ultraviolet-A) to strengthen the corneal tissue inter and intrafibrillar collagen bonds thus preventing further thinning, corneal protrusion and reduces corneal irregular astigmatism.
Eligibility Criteria
You may qualify if:
- Patients with progressive keratoconus (maximum K-reading between 46 diopters and 56 diopters), clear cornea and corneal pachymetry \> 380um.
You may not qualify if:
- Corneal scarring.
- Advanced keratoconus (k-max \> 56 D).
- Corneal pachymetry (thinnest location) \< 380 µm.
- Epithelial healing disorders e.g.
- Recurrent corneal erosion syndrome.
- History of diseases that may delay corneal healing or predispose the eye for future complications (e.g. rheumatic disorders, glaucoma, uveitis, chemical burn, corneal dystrophy).
- History suggestive of herpetic keratitis because the UVR can activate herpes virus.
- Post-LASIK ectasia and/or previous corneal surgeries e.g. intrastromal corneal ring segments (INTACS).
- Pregnancy and breast-feeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Teba private eye centre
Asyut, 71111, Egypt
Related Publications (3)
Mrochen M. Current status of accelerated corneal cross-linking. Indian J Ophthalmol. 2013 Aug;61(8):428-9. doi: 10.4103/0301-4738.116075.
PMID: 23925330RESULTLi Y, Meisler DM, Tang M, Lu AT, Thakrar V, Reiser BJ, Huang D. Keratoconus diagnosis with optical coherence tomography pachymetry mapping. Ophthalmology. 2008 Dec;115(12):2159-66. doi: 10.1016/j.ophtha.2008.08.004. Epub 2008 Nov 5.
PMID: 18977536RESULTGreenstein SA, Shah VP, Fry KL, Hersh PS. Corneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg. 2011 Apr;37(4):691-700. doi: 10.1016/j.jcrs.2010.10.052.
PMID: 21420594RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kamel Abdelnaser, MD
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 13, 2019
First Posted
March 18, 2019
Study Start
October 1, 2016
Primary Completion
April 1, 2019
Study Completion
May 30, 2019
Last Updated
March 19, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share